구강 작열감 증후군의 약물적 치료 비교 연구

최효근; 정은정; 이원용; 김희진; 차원재; 하정훈

추천

검색

자료유형: 학술저널

저자정보: 최효근 정은정 이원용 김희진 차원재 하정훈

저널정보: 대한이비인후과학회 대한이비인후-두경부외과학회지 대한이비인후과학회지 두경부외과학 제55권 제11호

발행연도: 2012.1

수록면: 707 - 711 (5page)

이용수

📌

연구주제

📖

연구배경

🔬

연구방법

🏆

연구결과

초록· 키워드

오류제보하기

Background and Objectives Burning mouth syndrome (BMS) refers to a collection of symptoms of patients who complain about burning sensation of their mouths without any specific causes. Although this is not a rare disease, the etiology and effective treatment are not well established. We tried to compare the efficacy and side effects of the agents that are reported to be relatively effective to BMS. Subjects and Method Fifty-one patients who were diagnosed as BMS were chosen as candidates. Trazodone, Paroxetine, Clonazepam, and Gabapentin, which were known to be effective medicines for BMS in previous research were prescribed randomly. We prescribed medication for two weeks and evaluated patients for the effect and side effects at the end of the treat-ment. The medication was prescribed for 2 more weeks and the patients were evaluated again. Results Three of 11 (27.3%) patients were prescribed Trazodone, 8 of 12 (66.7%) Paroxetine, 8 of 14 (57.1%) Clonazepam and 12 of 14 (85.7%) Gabapentin. Q showed improvements after 4 weeks of medication. The differential effectiveness among the medications was not significant, except for the inferiority of Trazodone. Five of 11 (45.5%) patients who had been prescribed Trazodone, 2 of 12 (16.7%) who had been prescribed Paroxetine, 2 of 14 (14.3%) who had been prescribed Clonazepam, 2 of 14 (14.3%) who had been prescribed Gabapentin complained of side effects during 4 weeks of medication. Conclusion We can expect high success rates of treatment for burning mouth syndrome with Paroxetine, Clonazepam and Gabapentin. A further study for long term outcomes and side effects in large groups is warranted.

#Burning mouth syndrome #Clonazepam #Gabapentin #Paroxetine #Trazodone

참고문헌 (12)

참고문헌 신청

Ben-David B / 1999 / Gabapentin therapy for vulvodynia / Anesth Analg 89 (6) : 1459 ~ 1460

Femiano F / 2002 / Burning mouth syndrome (BMS): an open trial of comparative efficacy of alpha-lipoic acid (thioctic acid) with other therapies / Minerva Stomatol 51 (9) : 4

Femiano F / 2004 / Burning Mouth Syndrome: open trial of psychotherapy alone, medication with alpha-lipoic acid (thioctic acid), and combination therapy / Med Oral 9 (1) : 8

Gremeau-Richard C / 2004 / Topical clonazepam in stomatodynia: a randomised placebo-controlled study / Pain 108 (1-2) : 51 ~ 57

Grushka M / 1998 / An open-label, dose escalation pilot study of the effect of clonazepam in burning mouth syndrome / Oral Surg Oral Med Oral Pathol Oral Radiol Endod 86 (5)